DK365786D0 - PREPARATION FOR INTRAMUSCULAR INJECTION OF MEDICINAL PRODUCTS, VITAMINES OR VACCINES - Google Patents

PREPARATION FOR INTRAMUSCULAR INJECTION OF MEDICINAL PRODUCTS, VITAMINES OR VACCINES

Info

Publication number
DK365786D0
DK365786D0 DK365786A DK365786A DK365786D0 DK 365786 D0 DK365786 D0 DK 365786D0 DK 365786 A DK365786 A DK 365786A DK 365786 A DK365786 A DK 365786A DK 365786 D0 DK365786 D0 DK 365786D0
Authority
DK
Denmark
Prior art keywords
intramuscular injection
vitamines
vaccines
preparation
medicinal products
Prior art date
Application number
DK365786A
Other languages
Danish (da)
Other versions
DK365786A (en
Inventor
Faruk Hadziselimovic
Original Assignee
Mepha Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha Ag filed Critical Mepha Ag
Publication of DK365786A publication Critical patent/DK365786A/en
Publication of DK365786D0 publication Critical patent/DK365786D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The addition of pharmaceutically accepted hydrosoluble organic or inorganic calcium salts, particularly calcium glucoheptonate to a drug, vitamin or vaccine to be administered by intramuscular injection enables to obtain a painless injection without adding local anaesthetics.
DK365786A 1984-12-07 1986-07-31 PREPARATION FOR INTRAMUSCULAR INJECTION OF MEDICINAL PRODUCTS, VITAMINES OR VACCINES DK365786D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH586084 1984-12-07
PCT/CH1985/000172 WO1986003413A1 (en) 1984-12-07 1985-12-06 Preparations for the intramuscular injection of drugs, vitamins or vaccines

Publications (2)

Publication Number Publication Date
DK365786A DK365786A (en) 1986-07-31
DK365786D0 true DK365786D0 (en) 1986-07-31

Family

ID=4300514

Family Applications (1)

Application Number Title Priority Date Filing Date
DK365786A DK365786D0 (en) 1984-12-07 1986-07-31 PREPARATION FOR INTRAMUSCULAR INJECTION OF MEDICINAL PRODUCTS, VITAMINES OR VACCINES

Country Status (9)

Country Link
EP (1) EP0204737B1 (en)
KR (1) KR870700024A (en)
AT (1) ATE74523T1 (en)
AU (1) AU5198686A (en)
DE (1) DE3585835D1 (en)
DK (1) DK365786D0 (en)
FI (1) FI863192A (en)
NO (1) NO863082D0 (en)
WO (1) WO1986003413A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267962B1 (en) 1990-12-21 2001-07-31 C-P Technology Limited Partnership Compositions and methods of treatment using peat derivatives
US5221254A (en) * 1991-04-02 1993-06-22 Alza Corporation Method for reducing sensation in iontophoretic drug delivery
NO20014746D0 (en) 2001-09-28 2001-09-28 Clas M Kjoelberg Pain reliever
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
WO2006012700A1 (en) * 2004-08-04 2006-02-09 Team Health Pty Ltd Method of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1023821A (en) * 1950-04-21 1953-03-24 Stable solution of calcium gluconate and process for its preparation
DE1007022B (en) * 1953-06-02 1957-04-25 Sandoz Ag Process for improving the shelf life and solubility of antihistamine preparations
DE1062389B (en) * 1958-02-11 1959-07-30 Wander Ag Dr A Process for the preparation of sterile vitamin D solutions containing calcium salts
US4081527A (en) * 1976-12-07 1978-03-28 Pfizer Inc. Chlortetracycline compositions

Also Published As

Publication number Publication date
AU5198686A (en) 1986-07-01
WO1986003413A1 (en) 1986-06-19
FI863192A0 (en) 1986-08-05
FI863192A (en) 1986-08-05
KR870700024A (en) 1987-02-28
EP0204737B1 (en) 1992-04-08
ATE74523T1 (en) 1992-04-15
DK365786A (en) 1986-07-31
EP0204737A1 (en) 1986-12-17
NO863082L (en) 1986-07-30
NO863082D0 (en) 1986-07-30
DE3585835D1 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
ES2061799T3 (en) NEW MEDICATION PREPARATION AND PROCEDURE FOR ITS PREPARATION.
NO863620D0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
ES2061094T3 (en) A PROCEDURE FOR OBTAINING A FORMULATION TO DECREASE THE IMPERIOUS DESIRE OF ALCOHOL (CRAVING) IN THE TREATMENT OF CHRONIC ALCOHOLISM.
ES2069582T3 (en) THERAPEUTIC NUCLEOSIDES.
ES2074124T3 (en) COMPOSITION IN THE FORM OF A FOAM CONTAINING 5-AMINOSALICYLIC ACID FOR INTRA-RECTAL ADMINISTRATION.
DK156375C (en) PREPARATIONS FOR ORAL ADMINISTRATION FOR DRUGS WITH LONG-TERM MEDICINAL DELIVERY
ES2162615T3 (en) METHOD TO TREAT OR PREVENT TYPE 1 DIABETES THROUGH ORAL INSULIN ADMINISTRATION.
NO306377B1 (en) Dosage form for delivery of a drug
PT90049A (en) DOSAGE FORM FOR ADMINISTERING A HUMAN THERAPY MEDICINE
FI891774A0 (en) Process for preparing a form of administration and / or dosage form of a drug
ES2059312T3 (en) MEDICATION THAT CAN BE ADMINISTERED BY THE NASAL VIA, PROCEDURE FOR ITS PREPARATION AND ITS APPLICATION.
SE8002715L (en) INJECTABLE MEDICINAL PRODUCTS WITH INFLAMMATION DISABILITY EFFECT AND SET FOR PREPARATION THEREOF
DK365786D0 (en) PREPARATION FOR INTRAMUSCULAR INJECTION OF MEDICINAL PRODUCTS, VITAMINES OR VACCINES
KR910005858A (en) Fatty acid therapy
IT1241079B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
ES2079851T3 (en) USE OF IL-4 TO IMPROVE THE IMMUNE RESPONSE AGAINST IMMUNOGEN IN VACCINES.
SE8501312L (en) ORAL DOSAGE FORM FOR ETOPSIDE
ES2081279T3 (en) USE OF 15-DESOXIESPERGUALINE AS A MEDICATION.
SE7708622L (en) 2-BENZYL-PERHYDROAZEPINES, PREPARATIONS AND MEDICINAL PRODUCTS, CONTAINING THEM
AR002946A1 (en) A SET FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOPOROSIS IN MAMMALS ACCORDING TO A CYCLIC DIET.
IT1213464B (en) PHARMACEUTICAL FORM FOR ENTERICAL ADMINISTRATION OF ETHODOLIC ACID OR ITS SALTS, IN MIXTURE WITH EXCIPIENTS.
SE8105500L (en) PSYCHOTROPA MEDICINAL PRODUCTS
BR9808876A (en) Medicine delivery system

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment